GMED241220C85000
- 0.32
- -0.43-57.33%
Globus Medical Newsroom
Jefferies Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $100
Jefferies Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $100
Globus Medical (GMED) Gets a Buy From Jefferies
CCORF Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $92
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $91
Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $95
Globus Medical Analyst Ratings
Wells Fargo Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $95
Globus Medical Is Maintained at Buy by Canaccord Genuity
Globus Medical Price Target Raised to $92.00/Share From $85.00 by Canaccord Genuity
CCORF Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $92
Globus Medical Raised to Overweight From Equal-Weight by Morgan Stanley
Globus Medical Analyst Ratings
Morgan Stanley Initiates Globus Medical(GMED.US) With Buy Rating, Announces Target Price $100
JMP Securities Maintains Globus Medical(GMED.US) With Hold Rating
Globus Medical's Strong Q3 Performance and Conservative Outlook Justify Hold Rating Amid Merger Challenges
Morgan Stanley Maintains Globus Medical(GMED.US) With Hold Rating, Raises Target Price to $83
Globus Medical Is Maintained at Equal-Weight by Morgan Stanley
Globus Medical Analyst Ratings
Barclays Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100